Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
PAAB Forum Quarterly Review - Q1/2023
-
Happy Spring @Manufacturer and @Agency
The first quarter of 2023 has been a big one. We've launched consultation on two draft guidance documents, posted additional guidance on gating, and an advisory on formulary claims, launched the Customer Experience Index (CEI) and more. See the PAAB Forum Quarterly Review to get caught up on all the action in Q1.
Please be advised
PAAB modified business hours for 2023 will start on Monday May 1st and end on Friday October 6th.PAAB summer business operating hours will be:
Monday to Thursday 8:30 - 5:30pm
Friday 8:30 - 1:15pmPlease note: eFiles modified hours submission end times will be:
Monday - Thursday 4:30pm
Friday 12:15pmOn behalf of the PAAB staff, have a safe and happy spring season.
